Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.

Juraschek SP, Steffes MW, Selvin E.

Clin Chem. 2012 Dec;58(12):1648-55. doi: 10.1373/clinchem.2012.188367. Epub 2012 Sep 27.

2.

Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Parrinello CM, Selvin E.

Curr Diab Rep. 2014;14(11):548. doi: 10.1007/s11892-014-0548-3. Review.

3.

Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review.

Sarwar N, Aspelund T, Eiriksdottir G, Gobin R, Seshasai SR, Forouhi NG, Sigurdsson G, Danesh J, Gudnason V.

PLoS Med. 2010 May 25;7(5):e1000278. doi: 10.1371/journal.pmed.1000278. Review.

4.

Glycated albumin in diabetic patients with chronic kidney disease.

Zheng CM, Ma WY, Wu CC, Lu KC.

Clin Chim Acta. 2012 Oct 9;413(19-20):1555-61. doi: 10.1016/j.cca.2012.04.025. Epub 2012 May 10. Review.

PMID:
22579765
5.
6.

[Recent progress in evaluation of glycemic control by glycated protein and 1,5-AG].

Matsuyama T, Katayama Y, Fujita S.

Rinsho Byori. 1995 May;43(5):445-8. Review. Japanese.

PMID:
7783360
7.

[Laboratory markers for glycemia and their target].

Noda M, Izumi K.

Nihon Rinsho. 2002 Sep;60 Suppl 9:667-74. Review. Japanese. No abstract available.

PMID:
12387067
8.

HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions.

Ribeiro RT, Macedo MP, Raposo JF.

Curr Diabetes Rev. 2016;12(1):14-9. Review.

PMID:
26126638
9.

1,5-Anhydroglucitol and glycated albumin in glycemia.

Koga M.

Adv Clin Chem. 2014;64:269-301. Review.

PMID:
24938022
10.

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.

Lee JE.

Ann Pediatr Endocrinol Metab. 2015 Jun;20(2):74-8. doi: 10.6065/apem.2015.20.2.74. Epub 2015 Jun 30. Review.

11.

Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.

Danese E, Montagnana M, Nouvenne A, Lippi G.

J Diabetes Sci Technol. 2015 Mar;9(2):169-76. doi: 10.1177/1932296814567227. Epub 2015 Jan 14. Review.

12.

Misleading hemoglobin A1c levels in a patient with paroxysmal nocturnal hemoglobinuria.

Xia D, McShine R, Berg AH.

Am J Clin Pathol. 2014 Aug;142(2):261-5. doi: 10.1309/AJCPTK1HPR2KULJU. Review.

13.

Serum fructosamine as a screening test for type 2 diabetes.

Klonoff DC.

Diabetes Technol Ther. 2000 Winter;2(4):537-9. Review. No abstract available.

PMID:
11469616
14.

Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?

Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, Drechsler C, Lacatus R, Vanholder R, Nistor I; European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD.

Nephrol Dial Transplant. 2014 Dec;29(12):2167-77. doi: 10.1093/ndt/gfu006. Epub 2014 Jan 26. Review.

PMID:
24470517
15.

Glycated serum albumin: a potential disease marker and an intermediate index of diabetes control.

Raghav A, Ahmad J.

Diabetes Metab Syndr. 2014 Oct-Dec;8(4):245-51. doi: 10.1016/j.dsx.2014.09.017. Epub 2014 Oct 11. Review.

PMID:
25311816
Items per page

Supplemental Content

Write to the Help Desk